Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience
Authors:
- 8 August 2009
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 96 (3) , 403-408
Abstract
An American Academy of Neurology practice parameter recommends that long-term prophylactic anti-epileptic drugs (AED) should not be routine in patients with newly diagnosed brain tumors. However, prospective multi-center North American data shows that most newly diagnosed glioma patients receive prophylactic AED. We examined our own peri-operative AED practice patterns in newly-diagnosed patients with malignant glioma to determine if we deviate from published guidelines. A retrospective chart review was performed in adult patients with newly diagnosed malignant gliomas undergoing surgery in southern Alberta between January 2003 and December 2005. Demographic information, AED use, seizure incidence, adverse effects, tumor size, and tumor location were recorded. Of 164 eligible patients, 54 (33%) presented with seizures and all received AED. Prophylactic AED were given to 44 patients (27%). Peri-operative seizures (within 1 week) occurred in two patients without (3%) and no patients with seizure prophylaxis. Adverse AED reactions and adverse effects attributable to seizures were both rare. Prophylactic AED were continued >1 week post-op in 30 patients (18%). Patients receiving prophylactic AED were more likely to have had tumors involving the temporal lobe than those who did not (50 vs. 20%; P < 0.01). Patients receiving peri-operative AED prophylaxis were common, had a trend to reduced peri-operative seizures, and had few adverse effects. However, most of these patients were maintained on prophylactic AED continued beyond the first peri-operative week, contradicting published guidelines. Increased awareness of practice guidelines may help modify AED prescription patterns in malignant glioma patients.Keywords
This publication has 23 references indexed in Scilit:
- Epilepsy in patients with brain tumours: epidemiology, mechanisms, and managementThe Lancet Neurology, 2007
- Brain Tumor and Seizures: Pathophysiology and Its Implications for Treatment RevisitedEpilepsia, 2003
- Add‐on Phenytoin Fails to Prevent Early Seizures after Surgery for Supratentorial Brain Tumors: A Randomized Controlled StudyEpilepsia, 2002
- Seizure Disorders in Patients with Brain TumorsEuropean Neurology, 2001
- Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]Neurology, 2000
- A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumorsNeurology, 1996
- The Course of Seizure Disorders in Patients With Malignant GliomasArchives of Neurology, 1995
- Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy?Journal of Neurology, Neurosurgery & Psychiatry, 1992
- The role of radiation therapy following resection of single brain metastasis from melanomaNeurology, 1990
- Phenytoin and postoperative epilepsyJournal of Neurosurgery, 1983